Department of Diagnostic and Interventional Neuroradiology University Medical Center Hamburg-Eppendorf Hamburg Germany.
Department of Diagnostic and Interventional Neuroradiology Hospital Bremen-Mitte Bremen Germany.
J Am Heart Assoc. 2020 Mar 3;9(5):e014447. doi: 10.1161/JAHA.119.014447. Epub 2020 Feb 24.
Background Patients aged ≥90 were excluded or under-represented in past thrombectomy trials; thus, uncertainty remains whether treatment benefits can be expected regardless of age. This study investigates outcome and safety of thrombectomy in nonagenarians to improve decision making in a real-world setting. Methods and Results All currently available data of patients aged ≥90 enrolled in the GSR-ET (German Stroke Registry-Endovascular Treatment) were combined with a smaller cohort from 3 tertiary stroke centers. Baseline characteristics, procedural (Thrombolysis in Cerebral Infarction scale) and functional outcomes (modified Rankin Scale; mRS), as well as complications (symptomatic intracranial hemorrhage, serious adverse events; SAEs) were analyzed. Good functional outcome was defined as mRS ≤3 at 90-days. 203 patients with anterior circulation stroke and prestroke mRS ≤3 were included. The rate of successful recanalization (Thrombolysis in Cerebral Infarction scale ≥2b) was 75.9% (154/203). Good functional outcome (mRS ≤3) was observed in 21.6% (41 of 193) at 90-days. In-hospital mortality was 27.1% (55 of 203) and increased significantly at 90 days to 48.9% (93 of 190; <0.001). Symptomatic intracranial hemorrhage occurred in 3% (6 of 203) of patients. Logistic regression analysis identified Alberta Stroke Program Early CT Score (adjusted odds ratio, 1.93; 95% CI, 1.01-3.70; =0.046) and initial National Institute of Health Stroke Scale (adjusted odds ratio, 0.85; 95% CI, 0.76-0.97; =0.014) as independent predictors for good outcome. Patients with successful recanalization had a significant (=0.001) shift of mRS distribution with higher rates of good functional outcomes (23.8% [34 of 143] versus 14.9% [7 of 47]) and lower mortality at 90-days (46.8% [67 of 143] versus 55.3% [26 of 47]). Conclusions Despite high mortality and less frequent favorable outcome, our data suggest that thrombectomy is still effective and safe for nonagenarians. Decision making for thrombectomy in patients aged ≥90 should be based on a case-by-case basis with regard to initial National Institute of Health Stroke Scale and Alberta Stroke Program Early CT Score.
过去的血栓切除术试验排除或代表性不足≥90 岁的患者;因此,仍不确定无论年龄大小,是否都能预期到治疗益处。本研究旨在调查≥90 岁患者的血栓切除术的结局和安全性,以改善真实环境下的决策制定。
将德国卒中登记-血管内治疗(German Stroke Registry-Endovascular Treatment,GSR-ET)中所有年龄≥90 岁的患者的现有数据与 3 个三级卒中中心的较小队列进行了合并。分析了基线特征、程序(血栓切除术溶栓量表)和功能结局(改良 Rankin 量表;mRS)以及并发症(症状性颅内出血、严重不良事件;SAEs)。90 天的良好功能结局定义为 mRS≤3。共纳入了 203 例前循环卒中且发病前 mRS≤3 的患者。成功再通率(血栓切除术溶栓量表≥2b)为 75.9%(154/203)。90 天时,41 例(41/193)的功能结局良好(mRS≤3)。住院死亡率为 27.1%(55/203),90 天内显著增加至 48.9%(93/190;<0.001)。3%(6/203)的患者发生症状性颅内出血。Logistic 回归分析确定了 Alberta 卒中计划早期 CT 评分(调整后的优势比,1.93;95%CI,1.01-3.70;=0.046)和初始国立卫生研究院卒中量表(调整后的优势比,0.85;95%CI,0.76-0.97;=0.014)是良好结局的独立预测因素。成功再通的患者 mRS 分布明显改善,功能结局良好的比例更高(23.8%[34/143]比 14.9%[7/47]),90 天死亡率更低(46.8%[67/143]比 55.3%[26/47])(=0.001)。
尽管死亡率较高,预后较好的比例较低,但我们的数据表明,血栓切除术对 90 岁以上患者仍然是有效和安全的。对于年龄≥90 岁的患者,是否进行血栓切除术的决策应根据初始国立卫生研究院卒中量表和 Alberta 卒中计划早期 CT 评分进行个体化评估。